Literature DB >> 17110237

Apolipoprotein A1 and B.

Allan D Sniderman1, Santica M Marcovina.   

Abstract

This article reviews the evidence showing that apolipoprotein (apo) B and A-1 are superior to the conventional cholesterol indices as analytes in laboratory practice, indices of the lipoprotein-related risk for vascular disease, and measures of the adequacy of low-density lipoprotein-lowering therapy.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17110237     DOI： 10.1016/j.cll.2006.07.007

Source DB:  PubMed          Journal:  Clin Lab Med        ISSN： 0272-2712            Impact factor:   1.935


  8 in total

Review 1.  The metabolic syndrome.

Authors:  Marc-Andre Cornier; Dana Dabelea; Teri L Hernandez; Rachel C Lindstrom; Amy J Steig; Nicole R Stob; Rachael E Van Pelt; Hong Wang; Robert H Eckel
Journal:  Endocr Rev       Date:  2008-10-29       Impact factor: 19.871

2.  Comparative proteomic analysis of plasma proteins in patients with age-related macular degeneration.

Authors:  Xin-Rong Xu; Lu Zhong; Bing-Lin Huang; Yuan-Hua Wei; Xin Zhou; Ling Wang; Fu-Qiang Wang
Journal:  Int J Ophthalmol       Date:  2014-04-18       Impact factor: 1.779

3.  HBV inhibits apoB production via the suppression of MTP expression.

Authors:  Fu-Bing Wang; Cheng-Liang Zhu; Xinghui Liu; Guo-Sheng Gao
Journal:  Lipids Health Dis       Date:  2011-11-11       Impact factor: 3.876

4.  Apolipoprotein B Is Related to Metabolic Syndrome Independently of Low Density Lipoprotein Cholesterol in Patients with Type 2 Diabetes.

Authors:  Younghyup Lim; Soyeon Yoo; Sang Ah Lee; Sang Ouk Chin; Dahee Heo; Jae Cheol Moon; Shinhang Moon; Kiyoung Boo; Seong Taeg Kim; Hye Mi Seo; Hyeyoung Jwa; Gwanpyo Koh
Journal:  Endocrinol Metab (Seoul)       Date:  2015-06

5.  Effects of blood lipid stability on progression of carotid atherosclerosis.

Authors:  Yu Ding; Bo Li; Feng Tian; Shanshan Zhou; Yundai Chen
Journal:  Pak J Med Sci       Date:  2017 May-Jun       Impact factor: 1.088

6.  High throughput quantification of apolipoproteins A-I and B-100 by isotope dilution MS targeting fast trypsin releasable peptides without reduction and alkylation.

Authors:  Bryan A Parks; David M Schieltz; Michael L Andrews; Michael S Gardner; Jon C Rees; Christopher A Toth; Jeffrey I Jones; Lisa G McWilliams; Zsuzsanna Kuklenyik; James L Pirkle; John R Barr
Journal:  Proteomics Clin Appl       Date:  2017-04-03       Impact factor: 3.494

7.  Proteomics-based approach for differentiation of age-related macular degeneration sub-types.

Authors:  Sivapriya Sivagurunathan; Lakshmi Dhevi N Selvan; Aafaque Ahmad Khan; Sowmya Parameswaran; Harsha Bhattacharjee; Krishna Gogoi; Harsha Gowda; T S Keshava Prasad; Akhilesh Pandey; S Ashok Kumar; Pukhraj Rishi; Ekta Rishi; Dhanashree Ratra; Muna Bhende; Narayanan Janakiraman; Jyotirmay Biswas; Subramanian Krishnakumar
Journal:  Indian J Ophthalmol       Date:  2021-03       Impact factor: 1.848

8.  Apolipoprotein B but not LDL cholesterol is associated with coronary artery calcification in type 2 diabetic whites.

Authors:  Seth S Martin; Atif N Qasim; Nehal N Mehta; Megan Wolfe; Karen Terembula; Stanley Schwartz; Nayyar Iqbal; Mark Schutta; Roshanak Bagheri; Muredach P Reilly
Journal:  Diabetes       Date:  2009-06-02       Impact factor: 9.461
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.